The Food and Drug Administration (FDA), specifically its Center for Drug Evaluation and Research (CDER) and Office of New Drugs (OND), is announcing its intention to continue funding the Kidney Health Initiative (KHI). This grant opportunity invites applications for the renewal of an existing award, supporting ongoing efforts to advance kidney health. The continuation of this grant signifies the FDA’s commitment to fostering research and development in nephrology through collaborations with organizations like the American Society of Nephrology (ASN). The funding aims to facilitate innovative projects and clinical trials under the KHI framework, ultimately improving patient outcomes related to kidney disease. This initiative is vital for driving progress in kidney health by bridging the gap between scientific discovery and the development of new therapies.
Opportunity ID: 353918
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-24-041 |
| Funding Opportunity Title: | Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Agriculture Consumer Protection Food and Nutrition |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 01, 2024 |
| Last Updated Date: | May 01, 2024 |
| Original Closing Date for Applications: | Jul 03, 2024 |
| Current Closing Date for Applications: | Jul 03, 2024 |
| Archive Date: | Aug 02, 2024 |
| Estimated Total Program Funding: | $350,000 |
| Award Ceiling: | $350,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | American Society of Nephrology |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: |
The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND) is announcing its intent to accept and consider continuation of the award of a grant to the American Society of Nephrology (ASN) to support the Kidney Health Initiative (KHI). |
| Link to Additional Information: | RFA-FD-24-041 Funding Opportunity Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Terrin Brown
Grantor Email:terrin.brown@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Terrin Brown Grantor Email: terrin.brown@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-24-041 | FORM H | PKG00286177 | May 01, 2024 | Jul 03, 2024 | View |
Package 1
Mandatory forms
353918 RR_SF424_5_0-5.0.pdf
353918 PHS398_CoverPageSupplement_5_0-5.0.pdf
353918 RR_OtherProjectInfo_1_4-1.4.pdf
353918 PerformanceSite_4_0-4.0.pdf
353918 RR_KeyPersonExpanded_4_0-4.0.pdf
353918 RR_Budget_3_0-3.0.pdf
353918 PHS398_ResearchPlan_5_0-5.0.pdf
353918 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353918 RR_SubawardBudget30_3_0-3.0.pdf
353918 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
